<DOC>
	<DOCNO>NCT01843361</DOCNO>
	<brief_summary>The aim study determine prevalence rate risk factor chemical laboratory clopidogrel low-response ( CLR ) acute phase ischemic stroke .</brief_summary>
	<brief_title>Clopidogrel Response Acute Ischemic Stroke . The Bochumer CRISP Study</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>acute ischemic stroke admittance stroke unit clopidogrel medication consent prior bleed disorder severe liver disorder current gastrointestinal disorder congestive heart failure lifethreatening malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Clopidogrel</keyword>
	<keyword>Aggregometry</keyword>
	<keyword>Antiplatelet therapy</keyword>
	<keyword>Platelet function test</keyword>
</DOC>